Serenack en es it fr

Serenack Brand names, Serenack Analogs

Serenack Brand Names Mixture

  • No information avaliable

Serenack Chemical_Formula


Serenack RX_link

Serenack fda sheet

Serenack msds (material safety sheet)

Serenack MSDS

Serenack Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Serenack Molecular Weight

284.74 g/mol

Serenack Melting Point


Serenack H2O Solubility

Slightly soluble (50 mg/L)

Serenack State


Serenack LogP


Serenack Dosage Forms

Tablets; Injectable solution

Serenack Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Serenack Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Serenack Absorption

Essentially complete, with a bioavailability of 93%.

Serenack side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Serenack Patient Information

Serenack Organisms Affected

Humans and other mammals